FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133591006> ?p ?o ?g. }

• W2133591006 endingPage "105" @default.
• W2133591006 startingPage "103" @default.
• W2133591006 abstract "If we had robust evidence one way or the other to inform us on the use of thrombolytics in submassive pulmonary embolus (PE), we would not need this debate. But, we do not and, so, we do. The stakes are considered high both in favour and against thromobolysing submassive PE, so we cannot brush the debate under the carpet while we await the evidence. It is accepted that high-risk/massive PE, defined as haemodynamic instability, merits aggressive treatment due to unacceptable mortality, which outweighs the risk of haemorrhage. At the other end of the spectrum, patients with low-risk PE do not, such that they may even be treated as outpatients.This leaves a grey area in between. When faced with a patient with a large thrombus load with a right ventricle (RV) that is dilated and pressure-loaded, but who is normotensive, as the attending clinician, we know they are at increased risk of death and long-term complications, such as chronic thromboembolic pulmonary hypertension (CTEPH).1 ,2 We may fall back on the Hippocratic Oath to ‘ first, do no harm ’, but the fuller translation reads ‘I will use treatments for the benefit of the ill in accordance with my ability and my judgment, but from what is to their harm and injustice I will keep them ’. Thus, rather than hide behind a lack of evidence, we must review what we have and come to a balanced decision, and justify it.In proposing the argument that submassive PE should be treated with thrombolysis, we must first accept that direct mortality due to the PE itself, not confounding conditions, remains unacceptably high with anticoagulation alone. A more aggressive strategy is required. As long as the benefits of thrombolysis outweigh the risks, then thrombolysis offers the best currently available approach. When …" @default.
• W2133591006 created "2016-06-24" @default.
• W2133591006 creator A5083138609 @default.
• W2133591006 date "2013-04-26" @default.
• W2133591006 modified "2023-09-26" @default.
• W2133591006 title "Thrombolytic therapy for submassive pulmonary embolus? PRO viewpoint" @default.
• W2133591006 cites W1504860021 @default.
• W2133591006 cites W1984112504 @default.
• W2133591006 cites W1993443958 @default.
• W2133591006 cites W2003483974 @default.
• W2133591006 cites W2024687690 @default.
• W2133591006 cites W2044689068 @default.
• W2133591006 cites W2085984247 @default.
• W2133591006 cites W2107941853 @default.
• W2133591006 cites W2108490506 @default.
• W2133591006 cites W2133473187 @default.
• W2133591006 cites W2142862664 @default.
• W2133591006 cites W2151865217 @default.
• W2133591006 cites W2156573757 @default.
• W2133591006 cites W2169548288 @default.
• W2133591006 cites W4236325521 @default.
• W2133591006 doi "https://doi.org/10.1136/thoraxjnl-2013-203413" @default.
• W2133591006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23624534" @default.
• W2133591006 hasPublicationYear "2013" @default.
• W2133591006 type Work @default.
• W2133591006 sameAs 2133591006 @default.
• W2133591006 citedByCount "5" @default.
• W2133591006 countsByYear W21335910062013 @default.
• W2133591006 countsByYear W21335910062015 @default.
• W2133591006 countsByYear W21335910062016 @default.
• W2133591006 countsByYear W21335910062017 @default.
• W2133591006 crossrefType "journal-article" @default.
• W2133591006 hasAuthorship W2133591006A5083138609 @default.
• W2133591006 hasBestOaLocation W21335910061 @default.
• W2133591006 hasConcept C126322002 @default.
• W2133591006 hasConcept C164705383 @default.
• W2133591006 hasConcept C2776265017 @default.
• W2133591006 hasConcept C2778342025 @default.
• W2133591006 hasConcept C2911010281 @default.
• W2133591006 hasConcept C71924100 @default.
• W2133591006 hasConceptScore W2133591006C126322002 @default.
• W2133591006 hasConceptScore W2133591006C164705383 @default.
• W2133591006 hasConceptScore W2133591006C2776265017 @default.
• W2133591006 hasConceptScore W2133591006C2778342025 @default.
• W2133591006 hasConceptScore W2133591006C2911010281 @default.
• W2133591006 hasConceptScore W2133591006C71924100 @default.
• W2133591006 hasIssue "2" @default.
• W2133591006 hasLocation W21335910061 @default.
• W2133591006 hasLocation W21335910062 @default.
• W2133591006 hasLocation W21335910063 @default.
• W2133591006 hasLocation W21335910064 @default.
• W2133591006 hasOpenAccess W2133591006 @default.
• W2133591006 hasPrimaryLocation W21335910061 @default.
• W2133591006 hasRelatedWork W1994958058 @default.
• W2133591006 hasRelatedWork W1996931551 @default.
• W2133591006 hasRelatedWork W2009550119 @default.
• W2133591006 hasRelatedWork W2049234716 @default.
• W2133591006 hasRelatedWork W2070341358 @default.
• W2133591006 hasRelatedWork W2084532115 @default.
• W2133591006 hasRelatedWork W2279092180 @default.
• W2133591006 hasRelatedWork W2288862798 @default.
• W2133591006 hasRelatedWork W2416697796 @default.
• W2133591006 hasRelatedWork W3144186419 @default.
• W2133591006 hasVolume "69" @default.
• W2133591006 isParatext "false" @default.
• W2133591006 isRetracted "false" @default.
• W2133591006 magId "2133591006" @default.
• W2133591006 workType "article" @default.